We Serve

Research Tools

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve

What we do

Select Capabilities

All Capabilities

Competitive Analysis

Find the signal in the noise. An avalanche of data, including from your competitors, is generated every day. Identifying the key information isn’t enough – you need to understand what it means for you and the market. We have the tools, but more importantly, the insight, to help.

Patient / Diagnostic Journey Mapping

As the precision medicine technologies and treatments evolve, so does the patient journey. Understanding how your products and services fit into the patient journey, and the barriers or challenges you may face, is critical to realizing your market potential.

Voice-of-Customer Research

Unbiased. Unfiltered. If you want to know what your current or potential customers think, and what motivates their behavior, then you’ve come to right place. No one gets more comprehensive and nuanced information from real-world life science stakeholders than we do. Period.

Impact

Selected Work

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Pre-due diligence research on a potential acquisition target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Featured Team

Stephane Budel

Founding Partner

David Cavanaugh

Founding Partner

Miguel Edwards

Katie Maloney

Carl Schoellhammer

Data & Platforms

Pharma Real-Word Data & Evidence Market Report, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global real-world data and evidence (RWD/E) market from 2025 to 2030. RWD has become increasingly central in life sciences decision-making, empowering organizations to generate insights that enhance research, clinical development, and commercial decision-making. The market is expanding as data types diversify, spanning electronic health records, claims, imaging, and omics, and as analytics become more advanced through AI and federated data approaches. Key players include data aggregators, generators (e.g., Guardant Health, Natera), enablers (e.g., COTA, Aetion), as well as players that span multiple functions (e.g., Tempus, Flatiron, NashBio).

Global In Vitro Diagnostics Market Report, First Edition: 2025-2030

DeciBio’s Global In Vitro Diagnostics Market Report, First Edition: 2025-2030, is an in-depth, data-driven resource designed to support strategic decision-making in the IVD space. This report provides a summary of the current IVD landscape, as well as a forward-looking perspective of the IVD market from 2025 to 2030. Content includes a rigorous assessment of industry market size, growth and key trends. In addition, we provide detailed segmentation by modality, therapeutic area, and geography.

Proteomics Tools Report: Research & Clinical Markets, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global proteomics tools market from 2025 to 2030. These tools are fundamental to life sciences, enabling the analysis of proteins, the functional endpoints of biological pathways. The landscape is highly dynamic, with a clear duality: established, first-generation tools (e.g., IHC, ELISAs, Western blot) remain critical in clinical trials and routine diagnostics, while a high-growth research segment is driven by innovative technologies like high-plex affinity platforms and spatial proteomics. The vendor landscape includes large corporations such as Thermo Fisher Scientific and Roche, as well as specialized innovators like Olink, SomaLogic, and Quantum-Si.

Analytical Instrument Utilization Report

This report provides a summary of historical (2019-2025) and expected (2025-2027) analytical instrument use across academic core laboratories in the U.S., Europe, and APAC.

Insights Blog

Precision Medicine is evolving at a rapid pace

Discover how we can help